⌘K

Home/Filings/4/0001209191-14-014090

4//SEC Filing

ZIOPHARM ONCOLOGY INC 4

Accession 0001209191-14-014090

$TCRTCIK 0001107421operating

View on SEC.gov Company Profile

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 5:04 PM ET

Size

4.8 KB

Accession

0001209191-14-014090

Insider Transaction Report

Form 4

Period: 2014-02-22

ZIOPHARM ONCOLOGY INCZIOP

BELBEL CAESAR J

EVP, Chief Legal Officer & Sec

Transactions

Tax Payment
Common Stock
2014-02-22$4.40/sh−14,600$64,240→ 30,994 total

Footnotes (1)

[F1]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ZIOPHARM ONCOLOGY INC

CIK 0001107421

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001107421

Filing Metadata

Form type: 4
Filed: Feb 24, 7:00 PM ET
Accepted: Feb 25, 5:04 PM ET
Size: 4.8 KB

View on SEC.gov